Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Adenosine treatment thickens hair in Caucasian men with hair loss.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Fexofenadine may help treat alopecia areata.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Tofacitinib may help regrow hair in alopecia areata patients.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Tofacitinib treatment is used for teenagers with alopecia areata.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Agmatine may help reduce seizures linked to hormone changes in female rats.